Position in LYEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$217,241
+$90,438 QoQ
Shares Held
15,462
+31.2% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 87 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority
Sole 58%
Shared 0%
None 42%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. LYEL ranks #241 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in LYEL
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $217,241 | 15,462 | Shares | Sole | 2026-08-12 | |
| 2025-03-31 | $126,803 | 235,694 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $179,922 | 281,129 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $377,803 | 273,771 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $378,075 | 260,742 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $620,321 | 278,171 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $525,516 | 270,885 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $395,174 | 268,826 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $874,188 | 274,902 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $642,045 | 272,053 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $913,401 | 263,228 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,962,372 | 267,718 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,628,076 | 249,705 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $764,458 | 151,378 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $180,396 | 23,307 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $249,957 | 16,889 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||